Results 221 to 230 of about 41,794 (337)
Alcohol use disorder and use of rhythm control therapies in patients with atrial fibrillation: A nationwide cohort study. [PDF]
Vanhanen M +12 more
europepmc +1 more source
Iontophoretic transmyocardial drug delivery. A novel approach to antiarrhythmic drug therapy. [PDF]
Boaz Avitall +6 more
openalex +1 more source
ABSTRACT Introduction Premature ventricular contractions (PVCs) originating from the proximal left anterior fascicle (LAF) are rarely discussed. We aimed to describe the characteristics and ablation outcome of PVCs originating from the proximal LAF and propose a stepwise approach.
Xuan Hoang Le +23 more
wiley +1 more source
New cases expand the genotype, phenotype and therapeutic landscape of H syndrome
British Journal of Haematology, Volume 208, Issue 1, Page 363-366, January 2026.
Clément Triaille +10 more
wiley +1 more source
Outcomes of Focused Double Extrastimuli Mapping and Ablation in Ventricular Tachycardia
ABSTRACT Background Conventional substrate mapping for scar‐related ventricular tachycardia (VT) often fails to fully delineate critical arrhythmogenic components. Functional mapping strategies using extrastimuli have shown promise but are limited by procedural complexity.
Surachat Jaroonpipatkul +6 more
wiley +1 more source
Evaluation and Management of Recurrent Atrial Flutter in Neonates. [PDF]
Aravindan N, Gaskin PRA, Vashist S.
europepmc +1 more source
The Role of MicroRNAs in Antiarrhythmic Therapy for Atrial Fibrillation. [PDF]
Clauss S, Sinner MF, Kääb S, Wakili R.
europepmc +1 more source
Effect of glucagon‐like peptide‐1 receptor agonist therapy on cardiorenal outcomes in patients aged ≥ 80 years with Type 2 diabetes. ABSTRACT Background Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) have demonstrated potential in improving glycemic control and reducing adverse outcomes in patients with Type 2 diabetes mellitus (T2DM); however ...
Jui‐Cheng Chen +4 more
wiley +1 more source
Early substrate-based catheter ablation vs. antiarrhythmic drug therapy for ventricular tachyarrhythmias among patients with prior myocardial infarction: the MANTRA-VT randomized trial. [PDF]
Raatikainen P +13 more
europepmc +1 more source

